Profile: Teleflex Inc (TFX.N)
24 Mar 2017
Teleflex Incorporated, incorporated on June 25, 1943, is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company markets and sells its products to hospitals and healthcare providers, across the world, through a combination of its direct sales force and distributors. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM). The Company manufactures its products at approximately 30 manufacturing sites, with manufacturing operations located in the Czech Republic, Germany, Malaysia, Mexico and the United States.
The Company's all others businesses include single-use respiratory, urology and cardiac care products, as well as capital equipment, which are provided to hospitals and other alternative channels of care. The Company's all other business also include its Latin American business. Its respiratory products are used in a range of care settings. The products include oxygen therapy products, aerosol therapy products, spirometry products, and ventilation management products. The Company offers Hudson RCI brand. The Company's specialty product line of urology products provides bladder management. The product portfolio consists of a range of catheters, including Foley, intermittent, external and suprapubic; urine collectors; catheterization accessories, and products for operative endourology marketed under the Rusch brand name. The Company's products in cardiac care product portfolio include diagnostic and intra-aortic balloon catheters and capital equipment. Its diagnostic catheters include thermodilution and wedge pressure catheters; specialized catheters used during the x-ray examination of blood vessels, such as Berman and Reverse Berman catheters; therapeutic delivery catheters, such as temporary pacing catheters; sheaths for femoral and trans-radial aortic access used in diagnostic and therapeutic procedures, and intra-aortic balloon (IAB), catheters. Capital equipment includes its intra-aortic balloon pump (IABP) consoles. The Company markets its cardiac care products under the Arrow brand name.
Vascular North America
The Company's Vascular North America segment consists of its North American vascular and interventional access businesses, which offer products that facilitate a variety of critical care therapies and other applications. The Company's vascular access products primarily consist of its Arrow branded catheters and related devices that are used in a range of procedures, including the administration of intravenous medications and other therapies, the measurement of blood pressure and the withdrawal of blood samples through a single puncture site. The vascular access product portfolio principally consists of Arrow Central Venous Catheters (CVCs), Arrow EZ-IO Intraosseous Vascular Access System, Arrow Peripherally Inserted Central Catheters (PICCs), Arrow Jugular Axillo-subclavian Central Catheters (JACCs), VPS G4 Vascular Positioning System, Arrow Arterial Catheterization Sets and Arrow Percutaneous Sheath Introducers. The Company's CVCs are treated with its ARROWg+ard or ARROWg+ard Blue Plus antimicrobial surface treatments. The Company's PICCs and JACCs are available with its Chlorag+ard technology, which is an antimicrobial treatment applied to the external surface of the catheter body, as well as the entire fluid pathway of the catheter. The Company also offers its vascular access catheters in Maximal Barrier Precautions trays. Its ErgoPACK system offers clinicians a range of tray configurations.
The Company's interventional access products are used in a range of applications, including dialysis, oncology and critical care therapies. The Company's interventional access portfolio also includes Arrow branded products, such as diagnostic and drainage kits, embolectomy balloons, and reinforced percutaneous sheath introducers. The Company's interventional access products include Arrow OnControl Powered Bone Marrow / Bone Access System, Arrow Trerotola Percutaneous Thrombectomy Device (PTD), Arrow Chronic Hemodialysis Catheters and Arrow Acute Hemodialysis Catheters.
Anesthesia North America
The Company's Anesthesia North America segment consists of its North American airway management and pain management businesses. The Company's airway management products and related devices consist principally of LMA Airways, LMA Atomization, and RUSCH Endotracheal Tubes and Laryngoscopes. The Company's LMA laryngeal masks are used by anesthesiologists and emergency responders to establish an airway to channel anesthesia gas or oxygen to a patient's lungs during surgery or trauma. The LMA Protector Airway, its airway management device, is the single-use laryngeal mask with a dual gastric drainage channel and pharyngeal chamber. Its LMA atomization portfolio includes products designed to facilitate atomized delivery of certain medications. The LMA atomization portfolio includes LMA MAD Nasal, an intranasal mucosal atomization device. It offers a portfolio of products to facilitate and support endotracheal intubation to administer oxygen, and anesthetic gases in multiple settings (surgery, critical care and emergency settings). It also provides a range of products for laryngoscopy.
The Company's pain management products, which are designed for use in a range of surgical and obstetric procedures, consist principally of Arrow Epidural Catheters, Needles and Kits; Arrow Peripheral Nerve Block (PNB) Catheters, Pumps, Needles and Kits; AutoFuser Disposable Pain Pumps, and Arrow EZ-IO System. The Company offers a range of Arrow epidural products, including the Arrow FlexTip Plus epidural catheter, to facilitate epidural analgesia. The Company's portfolio of Arrow PNB products includes the Arrow Stimucath and FlexBlock catheters.
Surgical North America
The Company's surgical products are designed to provide surgeons with a range of devices for use in a range of surgical procedures. The Company's portfolio consists of both single-use and reusable products. The Company's Weck Ligation Systems features the Weck Ligating Clips and Hem-o-lok Ligating Clips. Its Weck EFx endo fascial closure system is a port site closure device used in laparoscopic surgical procedures. Its Mini-Lap surgical instruments are designed to be inserted percutaneously (through the skin) to enable surgeons to perform laparoscopic surgery. The Company has developed its Percuvance percutaneous surgical system with approximately five-millimeter attachments. Its other branded surgical products include its Weck Vista bladeless access ports, Deknatel sutures and its Pilling and Kmedic surgical instruments.
Europe, the Middle East and Africa (EMEA
The EMEA segment designs, manufactures and distributes medical devices used in critical care, surgical applications and cardiac care and serves over two end markets: hospitals and healthcare providers, and home health. The products of the EMEA segment are used in the acute care setting for a range of diagnostic and therapeutic procedures and in general and specialty surgical applications, including urology.
The Company's Asia segment designs, manufactures and distributes medical devices used in critical care, surgical applications and cardiac care, and serves hospitals and healthcare providers. The products of the Asia segment are used in the acute care setting for a range of diagnostic and therapeutic procedures and in general and specialty surgical applications.
The OEM segment designs, manufactures and supplies devices and instruments for other medical device manufacturers. OEM division, which includes the TFX OEM and Deknatel OEM brands, provides extrusions, diagnostic and interventional catheters, sheath/dilator sets (introducers) and kits, sutures, performance fibers and bioresorbable resins and fibers. The Company offers a portfolio of integrated capabilities, including engineering, material selection, regulatory affairs, prototyping, testing and validation, manufacturing, assembly and packing.
The Company competes with C. R. Bard, Inc., Medtronic plc and Becton, Dickinson and Company.
550 E Swedesford Rd Ste 400
WAYNE PA 19087-1601
Company Web Links
- BRIEF-Teleflex announces U.S. commercial launch of spectre guidewire
- BRIEF-Teleflex posts Q4 EPS of $1.29 from continuing operations
- BRIEF-Teleflex announces 510(k) clearance and US launch of trapliner catheter
- BRIEF-Vascular Solutions shareholders approve acquisition by Teleflex
- BRIEF-Teleflex amends, restates existing credit agreement